Generalized morphea - a case report

Aneela Asghar, Saira Riaz, Tahir Jamil Ahmad

Abstract


Generalized morphea is a subtype of morphea in which widespread sclerotic plaques are seen without systemic involvement. We are reporting a case of 10-year-old boy with generalized morphea for 6 years

Keywords


Morphea, localized scleroderma, generalized morphea

Full Text:

PDF

References


Mayes MD. Classification and epidemiology of scleroderma. Semin Cutan Med Surg. 1998;17:26-6.

Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995;70:1068-76.

Fett N, Werth VP. Update on morphea: part-I. Epidemiology, clinical presentation and pathogenesis. J Am Acad Dermatol. 2011;64:217-28.

Johnson W, Jacabe H. Morphea in adults and children cohort II: Patients with morphea experience delay in diagnosis and large variation in treatment. J Am Acad Dermatol. 2012;67:881-9.

Zulian F, Ather BH, Loxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2006;45:614-20.

Arif T, Hassan I. Generalized morphea and hypothyroidism: Case report of a rare association. J Pak Assoc Dermatol. 2015;25:223-6.

Sato S, Ihn H, Sama Y, Igarashi A, Tamaki T, Kikuchi K et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum. 1993;36:1137-41.

Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumberg-Lever G, Lange R et al. Detection of Borrelia Burgdorferi DNA (B gainii or B afzelii) in morphea and lichen sclerosis et atrophicus tissue of German and Japanese but not of us patients. Arch Dermatol. 1997;133:41-4.

Wlaschet M, Heinen G, Poswig A, Schwag A, Krieg T, Scharggetter-Kochanek K. UVA induced autocrine stimulation of fibroblast-derived collagenase/MMP by interrelated loops of interleeutin-1 and interleukin-6. Phtochem Phtobiol. 1994;59:550-6.

Hwang BM, Noh EM, Kim JS, Kim JM, You YO, Hwang JK et al. Curcumin inhibits UVB-induced matrix metalloproteinase-1/3 expression by suppressing the MAPK-p38/JNK pathways in human dermal fibroblasts. Exp Dermatol. 2013;22:371-4.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014